Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present
出版年份 2014 全文链接
标题
Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 3, Pages 295-304
出版商
Informa Healthcare
发表日期
2014-01-04
DOI
10.1517/13543784.2014.867017
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- New Roles of Cyclin D1
- (2013) Richard G. Pestell AMERICAN JOURNAL OF PATHOLOGY
- A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies
- (2013) John J Nemunaitis et al. Journal of Translational Medicine
- Emerging drug profile: cyclin-dependent kinase inhibitors
- (2013) James S. Blachly et al. LEUKEMIA & LYMPHOMA
- Cyclin D1 Determines Estrogen Signaling in the Mammary Gland In Vivo
- (2013) Mathew C. Casimiro et al. MOLECULAR ENDOCRINOLOGY
- The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling
- (2013) Brijal M. Desai et al. PLoS One
- Inhibition of UBE2D3 Expression Attenuates Radiosensitivity of MCF-7 Human Breast Cancer Cells by Increasing hTERT Expression and Activity
- (2013) Wenbo Wang et al. PLoS One
- Apoptosis of osteosarcoma cultures by the combination of the cyclin-dependent kinase inhibitor SCH727965 and a heat shock protein 90 inhibitor
- (2013) W Fu et al. Cell Death & Disease
- The Requirement for Cyclin D Function in Tumor Maintenance
- (2012) Yoon Jong Choi et al. CANCER CELL
- Losing balance: the origin and impact of aneuploidy in cancer
- (2012) Andrew J Holland et al. EMBO REPORTS
- Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number
- (2012) V. G. Sankaran et al. GENES & DEVELOPMENT
- ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice
- (2012) Mathew C. Casimiro et al. JOURNAL OF CLINICAL INVESTIGATION
- Chromosomal instability and cancer: a complex relationship with therapeutic potential
- (2012) Samuel F. Bakhoum et al. JOURNAL OF CLINICAL INVESTIGATION
- Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy
- (2012) Patrick J. Roberts et al. JNCI-Journal of the National Cancer Institute
- Synthesis of a New Series of Pyridine and Fused Pyridine Derivatives
- (2012) Siham AbdulRahman Al-Issa MOLECULES
- Initial testing (stage 1) of the cyclin dependent kinase inhibitor SCH 727965 (dinaciclib) by the pediatric preclinical testing program
- (2012) Richard Gorlick et al. PEDIATRIC BLOOD & CANCER
- Why nature chose phosphate to modify proteins
- (2012) T. Hunter PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells
- (2012) Yuan Sun et al. Journal of Cancer
- Sensitivity of malignant rhabdoid tumor cell lines to PD 0332991 is inversely correlated with p16 expression
- (2011) Yoshiki Katsumi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)
- (2011) G K Schwartz et al. BRITISH JOURNAL OF CANCER
- Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models
- (2011) Georg Feldmann et al. CANCER BIOLOGY & THERAPY
- Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
- (2011) Peter Friedl et al. CELL
- Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer
- (2011) K. T. Flaherty et al. CLINICAL CANCER RESEARCH
- Design, synthesis and biological study of novel pyrido[2,3-d]pyrimidine as anti-proliferative CDK2 inhibitors
- (2011) Diaa A. Ibrahim et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
- (2011) Siwanon Jirawatnotai et al. NATURE
- Cyclin D1 Kinase Activity Is Required for the Self-Renewal of Mammary Stem and Progenitor Cells that Are Targets of MMTV-ErbB2 Tumorigenesis
- (2010) Rinath Jeselsohn et al. CANCER CELL
- Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts
- (2010) K. Michaud et al. CANCER RESEARCH
- Alternative Cyclin D1 Splice Forms Differentially Regulate the DNA Damage Response
- (2010) Z. Li et al. CANCER RESEARCH
- SLUG-induced Elevation of D1 Cyclin in Breast Cancer Cells through the Inhibition of Its Ubiquitination
- (2010) Mukul K. Mittal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Whether to target single or multiple CDKs for therapy? That is the question
- (2010) Józefa Węsierska-Gądek et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
- (2010) David Parry et al. MOLECULAR CANCER THERAPEUTICS
- The regulation of protein phosphorylation
- (2009) Louise N. Johnson BIOCHEMICAL SOCIETY TRANSACTIONS
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- The decision to enter mitosis: feedback and redundancy in the mitotic entry network
- (2009) Arne Lindqvist et al. JOURNAL OF CELL BIOLOGY
- Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines
- (2009) M. S. Squires et al. MOLECULAR CANCER THERAPEUTICS
- A mechanism linking extra centrosomes to chromosomal instability
- (2009) Neil J. Ganem et al. NATURE
- Cell cycle kinases as therapeutic targets for cancer
- (2009) Silvia Lapenna et al. NATURE REVIEWS DRUG DISCOVERY
- To cell cycle, swing the APC/C
- (2008) Renske van Leuken et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Alternate Cyclin D1 mRNA Splicing Modulates p27KIP1Binding and Cell Migration
- (2008) Zhiping Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification ofN-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design†
- (2008) Paul G. Wyatt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cracking the RNA polymerase II CTD code
- (2008) Sylvain Egloff et al. TRENDS IN GENETICS
- Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening
- (2007) Taikou Usui et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- CDK inhibitors in cancer therapy: what is next?
- (2007) Marcos Malumbres et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started